1
|
Manchope MF, Mizokami SS, Ferraz CR, Borghi SM, Vignoli JA, Camilios-Neto D, Arakawa NS, Georgetti SR, Verri WA, Casagrande R. Pimenta pseudocaryophyllus (Gomes) Landrum extract inhibits inflammatory pain in mice: targeting neutrophil recruitment, oxidative stress, and cytokine production. Nat Prod Res 2022; 36:6081-6084. [PMID: 35227131 DOI: 10.1080/14786419.2022.2045487] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
Pimenta pseudocaryophyllus (Gomes) Landrum is a Brazilian native plant. The mechanisms by which it promotes analgesia are unknown. We demonstrated the analgesic effect of P. pseudocaryophyllus dried extract (3 mg/kg; i.p.) in the following models of inflammatory pain (maximal inhibition): phenyl-p-benzoquinone (89%), formalin (72% - 1st phase and 96% - 2nd phase for flinches, and 50% - 1st phase and 71% - 2nd phase for licking behavior), complete Freund's adjuvant (95% - flinches and 33% - licking behavior), and carrageenin (56% - mechanical and 85% - thermal hyperalgesia) without motor impairment. Its analgesic effect depends on inhibiting neutrophil recruitment (95% - histopathology, 83% - myeloperoxidase activity, and 80% - LysM-eGFP mice), oxidative stress (86% - GSH and 98% - superoxide anion), and cytokine production (35% - IL-33, 80% - TNF-α, and 95% - IL-1β). The present study advances in understanding the analgesic mechanisms of P. pseudocaryophyllus.
Collapse
Affiliation(s)
- Marília F Manchope
- Departamento de Ciências Patológicas, CCB, Universidade Estadual de Londrina, Rodovia Celso Garcia Cid, Londrina, Paraná, Brazil
| | - Sandra S Mizokami
- Departamento de Ciências Patológicas, CCB, Universidade Estadual de Londrina, Rodovia Celso Garcia Cid, Londrina, Paraná, Brazil
| | - Camila R Ferraz
- Departamento de Ciências Patológicas, CCB, Universidade Estadual de Londrina, Rodovia Celso Garcia Cid, Londrina, Paraná, Brazil.,Departamento de Ciências Farmacêuticas, CCS, Universidade Estadual de Londrina, Londrina, Paraná, Brazil
| | - Sergio M Borghi
- Departamento de Ciências Patológicas, CCB, Universidade Estadual de Londrina, Rodovia Celso Garcia Cid, Londrina, Paraná, Brazil.,Centro de Pesquisa em Ciências da Saúde, Universidade Norte do Paraná, Londrina, Paraná, Brazil
| | - Josiane A Vignoli
- Departamento de Bioquímica e Biotecnologia, CCE, Universidade Estadual de Londrina, Rodovia Celso Garcia Cid, Londrina, Paraná, Brazil
| | - Doumit Camilios-Neto
- Departamento de Bioquímica e Biotecnologia, CCE, Universidade Estadual de Londrina, Rodovia Celso Garcia Cid, Londrina, Paraná, Brazil
| | - Nilton S Arakawa
- Departamento de Ciências Farmacêuticas, CCS, Universidade Estadual de Londrina, Londrina, Paraná, Brazil
| | - Sandra R Georgetti
- Departamento de Ciências Farmacêuticas, CCS, Universidade Estadual de Londrina, Londrina, Paraná, Brazil
| | - Waldiceu A Verri
- Departamento de Ciências Patológicas, CCB, Universidade Estadual de Londrina, Rodovia Celso Garcia Cid, Londrina, Paraná, Brazil
| | - Rubia Casagrande
- Departamento de Ciências Farmacêuticas, CCS, Universidade Estadual de Londrina, Londrina, Paraná, Brazil
| |
Collapse
|
2
|
Soares GABE, Bhattacharya T, Chakrabarti T, Tagde P, Cavalu S. Exploring Pharmacological Mechanisms of Essential Oils on the Central Nervous System. PLANTS (BASEL, SWITZERLAND) 2021; 11:plants11010021. [PMID: 35009027 PMCID: PMC8747111 DOI: 10.3390/plants11010021] [Citation(s) in RCA: 20] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/29/2021] [Revised: 12/15/2021] [Accepted: 12/19/2021] [Indexed: 06/01/2023]
Abstract
Essential oils (EOs) have been traditionally used as ancient remedies to treat many health disorders due to their enormous biological activities. As mainstream allopathic medication currently used for CNS disorders is associated with adverse effects, the search to obtain safer alternatives as compared to the currently marketed therapies is of tremendous significance. Research conducted suggests that concurrent utilization of allopathic medicines and EOs is synergistically beneficial. Due to their inability to show untoward effects, various scientists have tried to elucidate the pharmacological mechanisms by which these oils exert beneficial effects on the CNS. In this regard, our review aims to improve the understanding of EOs' biological activity on the CNS and to highlight the significance of the utilization of EOs in neuronal disorders, thereby improving patient acceptability of EOs as therapeutic agents. Through data compilation from library searches and electronic databases such as PubMed, Google Scholar, etc., recent preclinical and clinical data, routes of administration, and the required or maximal dosage for the observation of beneficial effects are addressed. We have also highlighted the challenges that require attention for further improving patient compliance, research gaps, and the development of EO-based nanomedicine for targeted therapy and pharmacotherapy.
Collapse
Affiliation(s)
- Giselle A. Borges e Soares
- Department of Medicinal and Biological Chemistry, University of Toledo, 3000 Arlington Ave., Toledo, OH 43614, USA;
| | - Tanima Bhattacharya
- Innovation, Incubation & Industry (I-Cube) Laboratory, Techno India NJR Institute of Technology, Udaipur 313003, Rajasthan, India
- Department of Science & Engineering, Novel Global Community Educational Foundation, Hebersham, NSW 2770, Australia
| | - Tulika Chakrabarti
- Department of Chemistry, Sir Padampat Singhania University, Udaipur 313601, Rajasthan, India;
| | - Priti Tagde
- Bhabha Pharmacy Research Institute, Bhabha University Bhopal, Bhopal 462026, Madhya Pradesh, India;
- PRISAL Foundation (Pharmaceutical Royal International Society), Bhopal 462042, India
| | - Simona Cavalu
- Faculty of Medicine and Pharmacy, University of Oradea, P-ta 1 Decembrie 10, 410087 Oradea, Romania
| |
Collapse
|
3
|
Garola F, Gilligan G, Panico R, Leonardi N, Piemonte E. Clinical management of alveolar osteitis. A systematic review. Med Oral Patol Oral Cir Bucal 2021; 26:e691-e702. [PMID: 34704976 PMCID: PMC8601644 DOI: 10.4317/medoral.24256] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2020] [Accepted: 09/27/2021] [Indexed: 11/06/2022] Open
Abstract
Background Alveolar Osteitis (AO) is one of the most common complications of tooth extraction. Several therapeutic interventions have been described for the treatment of AO, however, there are no treatment standardized protocols. The aim of this study was to conduct a systematic review on the efficacy in pain control of the different treatments for AO. The feasibility of the application of these interventions is also discussed. Material and Methods A structured electronic and hand search strategy was applied to PubMed, Scopus, Cochrane Library, OpenGrey, and Google Scholar between January 2010 and July 2020 to identify studies according to PRISMA guidelines. The inclusion criteria were original English and Spanish clinical trials that analyzed pain-control parameters according to visual analog scale (VAS, 0-10 scale), or pain relief patients’ percentages. Those treatments that reach VAS ≤ 4 on day 2 or before; or ≥ 85% of patients with absence of pain symptoms at day 7 or before were considered accepTable for their recommendation. Results The final review included 17 clinical trials. Among them, there were analyzed a total of 39 different AO treatments. 53,8% of the treatments fulfill the proposed parameters for pain control. Conclusions Treatment alternatives are multiple, heterogeneous, and difficult to compare. The management of AO is summarized in basic (intra-alveolar irrigation) and specific procedures (Alveogyl®, Neocones®, SaliCept Patch®, Low-Level Laser, Platelet-Rich Fibrin) that reach pain control success. They could be selected according to their availability and advantages or disadvantages. Key words:Dry socket, alveolar osteitis, treatment, management, pain control, pain relief.
Collapse
Affiliation(s)
- F Garola
- Haya de la Torre SN PA: 5000. Ciudad Universitaria Córdoba, Argentina
| | | | | | | | | |
Collapse
|
4
|
Orumwensodia KO, Uadia PO, Choudhary MI. Phytotoxicity, cytotoxicity and chemical composition of Spondias mombin Linn. Stem bark. CLINICAL PHYTOSCIENCE 2021. [DOI: 10.1186/s40816-021-00297-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 04/03/2023] Open
Abstract
Abstract
Background
Spondias mombin Linn. is a tropical climate plant with wide applications in ethnomedicinal practice. This study evaluates the phytotoxicity, cytotoxicity and chemical composition of the plant’s stem bark.
Methods
Dried stem bark sample of Spondias mombin Linn. was subjected to exhaustive extraction and partitioned into sub-fractions (hexane-ethylacetate, ethylacetate, ethylacetate-methanol and methanol) by graded polarity technique. The phytotoxicity and cytotoxicity indices of the crude hydro-ethanol extract and fractions were evaluated using Lemna minor and brine shrimp lethality assays, respectively, while chemical composition of the oily hexane:ethylacetate fraction was determined by gas chromatography-mass spectroscopy (GC-MS) technique.
Results
Phytotoxicity was dose-dependent which ranged from low (crude plant extract), moderate (hexane-ethylacetate and methanol fractions), high (ethylaacetate-methanol fraction) to significant toxicity (ethylacetate fraction) at the highest dose. However, for brine shrimp lethality assay only hexane-ethylacetate (LD50: 284.02 μg/mL) and ethylacetate (LD50: 210.24 μg/mL) fractions were cytotoxic at the highest dose. The GC-MS profile of the oily hexane:ethylacetate fraction identified sixty-eight compounds comprising hydrocarbons, fatty acids, alcohols, steroids, nitrogen and fluoride-containing compounds, terpenes and esters.
Conclusion
This study concludes that fractions of Spondias mombin Lin. could be potentially toxic. While its phytotoxic potential can be useful in the agrochemical industry for the production of natural herbicides, its cytotoxic property can be cautiously harnessed for ethnomedicinal purposes.
Collapse
|
5
|
The effects of eugenol nanoemulsion on pain caused by arteriovenous fistula cannulation in hemodialysis patients: A randomized double-blinded controlled cross-over trial. Complement Ther Med 2020; 52:102440. [PMID: 32951708 DOI: 10.1016/j.ctim.2020.102440] [Citation(s) in RCA: 28] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2019] [Revised: 04/01/2020] [Accepted: 05/11/2020] [Indexed: 12/23/2022] Open
Abstract
OBJECTIVES Local anesthetic and antinociceptive activity of eugenol, as the main ingredient of clove, was determined in previous researches. This study aimed to assess the efficacy of its topical nanoemulsion gel vs. placebo in controlling pain caused by arteriovenous fistula (AVF) needling in patients undergoing hemodialysis (HD). DESIGN In this double-blinded cross-over trial, the patients were randomly allocated to eugenol gel 4% (n = 34) and placebo gel (n = 34) groups. For each patient, a tip of finger unit of gel was applied 2 cm around the insertion site of hemodialysis needles. After 10 min, AVF needling was done. AVF needling-related pain was assessed using visual analogue scale (VAS) immediately after the puncture. All patients were tested at three different states: (1) before using any intervention; (2) after using either the eugenol or placebo gel; and (3) after crossing over the groups. RESULTS There was a significant difference between the mean of patients' pain severity score in the three states (p = 0.001). It was reported as low as 3.29 ± 0.67 in patients who received eugenol nanoemulsion. Also, the highest pain severity score (5.03 ± 0.57) was reported at the no-intervention state. CONCLUSIONS It seems that topical application of eugenol nanoemulsion may significantly decrease AVF cannulation related pain intensity score in patients undergoing HD. However, further studies with larger sample size and longer intervention period should be done for better judgment on its efficiency and safety.
Collapse
|
6
|
Ghofran O, Safari T, Shahraki MR. Effects of Eugenol on Pain Response to the Formalin Test and Plasma Antioxidant Activity in High Fructose Drinking Water in Male Rats. Int J Prev Med 2019; 10:151. [PMID: 31579163 PMCID: PMC6767808 DOI: 10.4103/ijpvm.ijpvm_348_17] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2017] [Accepted: 04/03/2018] [Indexed: 11/21/2022] Open
Abstract
Background: Increased consumption of fructose in recent years has increased the risk of developing metabolic syndrome. In this syndrome, induction of oxidative stress, cellular dysfunction, and decrease of antioxidant capacity can change response to pain. Therefore, this study aims to investigate the antinociceptive and antioxidant effects of eugenol on metabolic syndrome induced by a fructose-rich diet in rats. Methods: The rats were randomly assigned to five groups, to be under experiment for eight weeks. The first, control group, the second fructose 10% plus tween 0.5% (Fr + veh), the third fructose 10% (Fr), and the fourth fructose 10% plus a single dose of eugenol 100 mg/kg (Fr + EoS). However, the fifth obtained fructose 10% plus a continuous dose of eugenol 20 mg/kg/day (Fr + EoC) for the last 10 days of the experiment. After formalin test, blood samples were taken from the animals’ hearts followed by analysis for biochemical factors. Results: This study shows that fructose administration does not change any pain response and there are not any changes in pain response between Fr group and control group. However, treatment with single and continuous dose of eugenol in Fr + EoS and Fr + EoC groups significantly decreases response to pain in the first and second phase of formalin test in comparison with Fr group (P<0.05). Continuous does of eugenol improved serum malondialdehyde and total antioxidant capacity levels in Fr + Eoc group in comparison with Fr group. Conclusions: In the present work, new findings suggest the beneficial effects of eugenol in pain relief, improved serum glucose, insulin levels, and improved antioxidant activity in metabolic syndrome.
Collapse
Affiliation(s)
- Omid Ghofran
- Department of Physiology, Zahedan University of Medical Sciences, Zahedan, Iran
| | - Tahereh Safari
- Department of Physiology, Zahedan University of Medical Sciences, Zahedan, Iran
| | | |
Collapse
|
7
|
Lugo-Lugo DE, Pozos-Guillén ADJ, Zapata-Morales JR, Rodríguez-Chong A, Rangel-López ADJ, Saavedra-Leos MZ, Vértiz-Hernández AA. Antinociceptive local activity of 4-allyl-1-hydroxy-2-methoxybenzene (eugenol) by the formalin test: an anti-inflammatory effect. BRAZ J PHARM SCI 2019. [DOI: 10.1590/s2175-97902019000118022] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
|
8
|
Analgesic-Like Activity of Essential Oil Constituents: An Update. Int J Mol Sci 2017; 18:ijms18122392. [PMID: 29232831 PMCID: PMC5751100 DOI: 10.3390/ijms18122392] [Citation(s) in RCA: 38] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2017] [Revised: 11/03/2017] [Accepted: 11/03/2017] [Indexed: 12/18/2022] Open
Abstract
The constituents of essential oils are widely found in foods and aromatic plants giving characteristic odor and flavor. However, pharmacological studies evidence its therapeutic potential for the treatment of several diseases and promising use as compounds with analgesic-like action. Considering that pain affects a significant part of the world population and the need for the development of new analgesics, this review reports on the current studies of essential oils’ chemical constituents with analgesic-like activity, including a description of their mechanisms of action and chemical aspects.
Collapse
|
9
|
Orofacial antinociceptive effect of Mimosa tenuiflora (Willd.) Poiret. Biomed Pharmacother 2017; 97:1575-1585. [PMID: 29793320 DOI: 10.1016/j.biopha.2017.11.001] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2017] [Revised: 10/17/2017] [Accepted: 11/03/2017] [Indexed: 02/08/2023] Open
Abstract
Mimosa tenuiflora (Willd.) Poiret, popularly known in Brazil as "jurema-preta" is widely used against bronchitis, fever, headache and inflammation. Its antioxidant, anti-inflammatory and antinociceptive potential has already been reported. To assess the orofacial antinociceptive effect of M. tenuiflora, ethanolic extracts of M. tenuiflora (leaves, twigs, barks and roots) were submitted to in vitro tests of antioxidant activity. The extract with the highest antioxidant potential was partitioned and subjected to preliminary chemical prospecting, GC-MS, measurement of phenolic content and cytotoxicity tests of the fraction with the highest antioxidant activity. The nontoxic fraction with the highest antioxidant activity (FATEM) was subjected to tests of acute and chronic orofacial nociception and locomotor activity. The possible mechanisms of neuromodulation were also assessed. The EtOAc fraction, obtained from the ethanolic extract of M. tenuiflora barks, was the one with the highest antioxidant potential and nontoxic (FATEM), and Benzyloxyamine was the major constituent (34.27%). FATEM did not alter the locomotor system of mice and reduced significantly the orofacial nociceptive behavior induced by formalin, glutamate, capsaicin, cinnamaldehyde or acidic saline compared to the control group. FATEM also inhibited formalin- or mustard oil-induced temporomandibular nociception. In addition, it also reduced mustard oil-induced orofacial muscle nociception. However, FATEM did not alter hypertonic saline-induced corneal nociception. Neuropathic nociception was reversed by treatment with FATEM. The antinociceptive effect of FATEM was inhibited by naloxone, L-NAME and glibenclamide. FATEM has pharmacological potential for the treatment of acute and neuropathic orofacial pain and this effect is modulated by the opioid system, nitric oxide and ATP-sensitive potassium channels. These results lead us to studies of isolation and characterization of bioactive principles.
Collapse
|
10
|
Pandey MK, Gupta SC, Nabavizadeh A, Aggarwal BB. Regulation of cell signaling pathways by dietary agents for cancer prevention and treatment. Semin Cancer Biol 2017; 46:158-181. [PMID: 28823533 DOI: 10.1016/j.semcancer.2017.07.002] [Citation(s) in RCA: 43] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2017] [Revised: 07/05/2017] [Accepted: 07/12/2017] [Indexed: 12/17/2022]
Abstract
Although it is widely accepted that better food habits do play important role in cancer prevention and treatment, how dietary agents mediate their effects remains poorly understood. More than thousand different polyphenols have been identified from dietary plants. In this review, we discuss the underlying mechanism by which dietary agents can modulate a variety of cell-signaling pathways linked to cancer, including transcription factors, nuclear factor κB (NF-κB), signal transducer and activator of transcription 3 (STAT3), activator protein-1 (AP-1), β-catenin/Wnt, peroxisome proliferator activator receptor- gamma (PPAR-γ), Sonic Hedgehog, and nuclear factor erythroid 2 (Nrf2); growth factors receptors (EGFR, VEGFR, IGF1-R); protein Kinases (Ras/Raf, mTOR, PI3K, Bcr-abl and AMPK); and pro-inflammatory mediators (TNF-α, interleukins, COX-2, 5-LOX). In addition, modulation of proteasome and epigenetic changes by the dietary agents also play a major role in their ability to control cancer. Both in vitro and animal based studies support the role of dietary agents in cancer. The efficacy of dietary agents by clinical trials has also been reported. Importantly, natural agents are already in clinical trials against different kinds of cancer. Overall both in vitro and in vivo studies performed with dietary agents strongly support their role in cancer prevention. Thus, the famous quote "Let food be thy medicine and medicine be thy food" made by Hippocrates 25 centuries ago still holds good.
Collapse
Affiliation(s)
- Manoj K Pandey
- Department of Biomedical Sciences, Cooper Medical School of Rowan University, Camden, NJ, USA.
| | - Subash C Gupta
- Department of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, India
| | - Ali Nabavizadeh
- Department of Biomedical Sciences, Cooper Medical School of Rowan University, Camden, NJ, USA
| | | |
Collapse
|
11
|
Kheawfu K, Pikulkaew S, Hamamoto H, Sekimizu K, Okonogi S. Influence of clove oil and eugenol on muscle contraction of silkworm (Bombyx mori). Drug Discov Ther 2017; 11:64-69. [PMID: 28458297 DOI: 10.5582/ddt.2017.01012] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Clove oil is used in fish anesthesia and expected to have a mechanism via glutamic receptor. The present study explores the activities of clove oil and its major compound, eugenol, in comparison with L-glutamic acid on glutamic receptor of silkworm muscle and fish anesthesia. It was found that clove oil and eugenol had similar effects to L-glutamic acid on inhibition of silkworm muscle contraction after treated with D-glutamic acid and kainic acid. Anesthetic activity of the test samples was investigated in goldfish. The results demonstrated that L-glutamic acid at 20 and 40 mM could induce the fish to stage 3 of anesthesia that the fish exhibited total loss of equilibrium and muscle tone, whereas clove oil and eugenol at 60 ppm could induce the fish to stage 4 of anesthesia that the reflex activity of the fish was lost. These results suggest that clove oil and eugenol have similar functional activities and mechanism to L-glutamic acid on muscle contraction and fish anesthesia.
Collapse
Affiliation(s)
- Kantaporn Kheawfu
- Nanoscience and Nanotechnology Program, The Graduate School, Chiang Mai University
| | - Surachai Pikulkaew
- Department of Food Animal Clinic, Faculty of Veterinary Medicine, Chiang Mai University
| | - Hiroshi Hamamoto
- Laboratory of Microbiology, Graduate School of Pharmaceutical Sciences, The University of Tokyo.,Teikyo University Institute of Medical Mycology
| | - Kazuhisa Sekimizu
- Laboratory of Microbiology, Graduate School of Pharmaceutical Sciences, The University of Tokyo.,Teikyo University Institute of Medical Mycology
| | - Siriporn Okonogi
- Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University.,Research Center of Pharmaceutical Nanotechnology, Chiang Mai University
| |
Collapse
|
12
|
Kim SR. Control of Granule Cell Dispersion by Natural Materials Such as Eugenol and Naringin: A Potential Therapeutic Strategy Against Temporal Lobe Epilepsy. J Med Food 2016; 19:730-6. [PMID: 27404051 DOI: 10.1089/jmf.2016.3712] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022] Open
Abstract
The hippocampus is an important brain area where abnormal morphological characteristics are often observed in patients with temporal lobe epilepsy (TLE), typically showing the loss of the principal neurons in the CA1 and CA3 areas of the hippocampus. TLE is frequently associated with widening of the granule cell layer of the dentate gyrus (DG), termed granule cell dispersion (GCD), in the hippocampus, suggesting that the control of GCD with protection of hippocampal neurons may be useful for preventing and inhibiting epileptic seizures. We previously reported that eugenol (EUG), which is an essential component of medicinal herbs and has anticonvulsant activity, is beneficial for treating epilepsy through its ability to inhibit GCD via suppression of mammalian target of rapamycin complex 1 (mTORC1) activation in the hippocampal DG in a kainic acid (KA)-treated mouse model of epilepsy in vivo. In addition, we reported that naringin, a bioflavonoid in citrus fruits, could exert beneficial effects, such as antiautophagic stress and antineuroinflammation, in the KA mouse model of epilepsy, even though it was unclear whether naringin might also attenuate the seizure-induced morphological changes of GCD in the DG. Similar to the effects of EUG, we recently observed that naringin treatment significantly reduced KA-induced GCD and mTORC1 activation, which are both involved in epileptic seizures, in the hippocampus of mouse brain. Therefore, these observations suggest that the utilization of natural materials, which have beneficial properties such as inhibition of GCD formation and protection of hippocampal neurons, may be useful in developing a novel therapeutic agent against TLE.
Collapse
Affiliation(s)
- Sang Ryong Kim
- 1 School of Life Sciences, Kyungpook National University , Daegu, Korea.,2 BK21 plus KNU Creative BioResearch Group, Kyungpook National University , Daegu, Korea.,3 Brain Science and Engineering Institute, Kyungpook National University , Daegu, Korea
| |
Collapse
|
13
|
Fonsêca DV, Salgado PRR, Aragão Neto HDC, Golzio AMFO, Caldas Filho MRD, Melo CGF, Leite FC, Piuvezam MR, Pordeus LCDM, Barbosa Filho JM, Almeida RN. Ortho-eugenol exhibits anti-nociceptive and anti-inflammatory activities. Int Immunopharmacol 2016; 38:402-8. [PMID: 27355133 DOI: 10.1016/j.intimp.2016.06.005] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2016] [Revised: 06/06/2016] [Accepted: 06/06/2016] [Indexed: 12/29/2022]
Abstract
Ortho-eugenol is a much used phenylpropanoid whose ability to reduce pain and inflammation has never been studied. Researching ortho-eugenol's antinociceptive and anti-inflammatory activity, and its possible mechanisms of action is therefore of interest. The administration of vehicle, ortho-eugenol (50, 75 and 100mg/kg i.p.), morphine (6mg/kg, i.p.) or dexamethasone (2mg/kg, s.c.) occurred 30min before the completion of pharmacological tests. Pretreatment with ortho-eugenol did not change motor coordination test results, but reduced the number of writhes and licking times in the writhing test and glutamate test, respectively. The reaction time from thermal stimulus was significantly increased in the hot plate test after administration of ortho-eugenol. Treatment with yohimbine reversed the antinociceptive effect of ortho-eugenol, suggesting involvement of the adrenergic system. In anti-inflammatory tests, ortho-eugenol inhibited acetic acid induced vascular permeability and leukocyte migration, reducing TNF-α and IL-1β by virtue of its suppression of NF-κB and p38 phosphorylated forms in the peritonitis test. From these results, ortho-eugenol antinociceptive effects mediated by the adrenergic system and anti-inflammatory activity through regulation of proinflammatory cytokines and phosphorylation of NF-kB and p38 become evident for the first time.
Collapse
Affiliation(s)
- Diogo V Fonsêca
- Postgraduate Program in Natural Products and Bioactive Synthetics (PgPNSB), Federal University of Paraíba (UFPB), João Pessoa, PB, Brazil; Laboratory of Psychopharmacology, Federal University of Paraíba (UFPB), João Pessoa, PB, Brazil
| | - Paula R R Salgado
- Laboratory of Psychopharmacology, Federal University of Paraíba (UFPB), João Pessoa, PB, Brazil
| | - Humberto de C Aragão Neto
- Postgraduate Program in Natural Products and Bioactive Synthetics (PgPNSB), Federal University of Paraíba (UFPB), João Pessoa, PB, Brazil; Laboratory of Psychopharmacology, Federal University of Paraíba (UFPB), João Pessoa, PB, Brazil
| | - Adriana M F O Golzio
- Laboratory of Psychopharmacology, Federal University of Paraíba (UFPB), João Pessoa, PB, Brazil
| | - Marcelo R D Caldas Filho
- Postgraduate Program in Natural Products and Bioactive Synthetics (PgPNSB), Federal University of Paraíba (UFPB), João Pessoa, PB, Brazil; Laboratory of Psychopharmacology, Federal University of Paraíba (UFPB), João Pessoa, PB, Brazil
| | - Cynthia G F Melo
- Postgraduate Program in Natural Products and Bioactive Synthetics (PgPNSB), Federal University of Paraíba (UFPB), João Pessoa, PB, Brazil; Laboratory of Psychopharmacology, Federal University of Paraíba (UFPB), João Pessoa, PB, Brazil
| | - Fagner C Leite
- Postgraduate Program in Natural Products and Bioactive Synthetics (PgPNSB), Federal University of Paraíba (UFPB), João Pessoa, PB, Brazil; Laboratory of Immunology, University of Paraíba (UFPB), João Pessoa, PB, Brazil
| | - Marcia R Piuvezam
- Postgraduate Program in Natural Products and Bioactive Synthetics (PgPNSB), Federal University of Paraíba (UFPB), João Pessoa, PB, Brazil; Laboratory of Immunology, University of Paraíba (UFPB), João Pessoa, PB, Brazil
| | | | - José M Barbosa Filho
- Postgraduate Program in Natural Products and Bioactive Synthetics (PgPNSB), Federal University of Paraíba (UFPB), João Pessoa, PB, Brazil
| | - Reinaldo N Almeida
- Postgraduate Program in Natural Products and Bioactive Synthetics (PgPNSB), Federal University of Paraíba (UFPB), João Pessoa, PB, Brazil; Laboratory of Psychopharmacology, Federal University of Paraíba (UFPB), João Pessoa, PB, Brazil.
| |
Collapse
|
14
|
Abstract
This paper is the thirty-sixth consecutive installment of the annual review of research concerning the endogenous opioid system. It summarizes papers published during 2013 that studied the behavioral effects of molecular, pharmacological and genetic manipulation of opioid peptides, opioid receptors, opioid agonists and opioid antagonists. The particular topics that continue to be covered include the molecular-biochemical effects and neurochemical localization studies of endogenous opioids and their receptors related to behavior, and the roles of these opioid peptides and receptors in pain and analgesia; stress and social status; tolerance and dependence; learning and memory; eating and drinking; alcohol and drugs of abuse; sexual activity and hormones, pregnancy, development and endocrinology; mental illness and mood; seizures and neurologic disorders; electrical-related activity and neurophysiology; general activity and locomotion; gastrointestinal, renal and hepatic functions; cardiovascular responses; respiration and thermoregulation; and immunological responses.
Collapse
Affiliation(s)
- Richard J Bodnar
- Department of Psychology and Neuropsychology Doctoral Sub-Program, Queens College, City University of New York, Flushing, NY 11367, United States.
| |
Collapse
|